Diabetes, Obesity and Metabolism is a monthly peer-reviewed medical journal established in 1999 covering research on diabetes, obesity, and metabolism. The journal has a 2023 Clarivate impact factor of 5.4. From Wikipedia
Research presented at ECO2025 reveals significant alcohol reduction in obese patients treated with semaglutide or liraglutide, highlighting promising therapeutic implications beyond weight loss.
